Marina Khodanovich, Anna Naumova, Daria Kamaeva, Victoria Obukhovskaya, Svetlana Vasilieva, Evgeny Schastnyy, Nadezhda Kataeva, Anastasia Levina, Marina Kudabaeva, Valentina Pashkevich, Marina Moshkina, Yana Tumentceva, Mikhail Svetlik
Background : Depression and cognitive impairment are recognized complications of COVID-19. This study aimed to assess cognitive performance in clinically diagnosed post-COVID depression (PCD, n = 25) patients using neuropsychological testing. Methods : The study involved 71 post-COVID patients with matched control groups: recovered COVID-19 individuals without complications (n = 18) and individuals without prior COVID-19 history (n = 19). A post-COVID depression group (PCD, n = 25) was identified based on psychiatric diagnosis, and a comparison group (noPCD, n = 46) included participants with neurological COVID-19 complications, excluding clinical depression...
March 1, 2024: Journal of Clinical Medicine